Oncology and Hematology - Global Oncology Academy

401-416 of 595

HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
MinuteCE®
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
0.75 program credits
- Shubham Pant, MD, MBBS
0.75 program credits
Diversity in HER2 Expression Among Gynecologic Cancers
Diversity in HER2 Expression Among Gynecologic Cancers
MinuteCE®
Diversity in HER2 Expression Among Gynecologic Cancers
0.75 program credits
- Ritu Salani, MD, MBA
0.75 program credits
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
MinuteCE®
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
0.75 program credits
- Shubham Pant, MD, MBBS
0.75 program credits
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
MinuteCE®
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
0.75 program credits
- Ritu Salani, MD, MBA
0.75 program credits
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
MinuteCE®
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
0.75 program credits
- Shubham Pant, MD, MBBS
- Ritu Salani, MD, MBA
0.75 program credits
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
MinuteCE®
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
0.75 program credits
- Ritu Salani, MD, MBA
0.75 program credits
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
MinuteCE®
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
0.75 program credits
- Ritu Salani, MD, MBA
0.75 program credits
HER2-Targeted ADCs in Advanced NSCLC: A Case-Based Approach to Targeted Treatment for Metastatic Disease
HER2-Targeted ADCs in Advanced NSCLC: A Case-Based Approach to Targeted Treatment for Metastatic Disease
CME/CE
HER2-Targeted ADCs in Advanced NSCLC: A Case-Based Approach to Targeted Treatment for Metastatic Disease
0.50 credits
- Justin Gainor, MD
- Jacob Sands, MD
0.50 credits
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
- Jody Takemoto, PhD, MEd
- David Braun
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
- Munir Ghesani, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Enhancing HCC Outcomes Through Multidisciplinary Care
Project Oncology®
Enhancing HCC Outcomes Through Multidisciplinary Care
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Lee, MD
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Project Oncology®
Optimizing HCC Screening: Strategies to Overcome Common Barriers
- Hannah Lee, MD
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
- Jody Takemoto, PhD, MEd
- David Braun, MD, PhD
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Project Oncology®
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
- Jody Takemoto, PhD, MEd
- Robert Wong, MD
Key Highlights from SNMMI 2024
Key Highlights from SNMMI 2024
Project Oncology®
Key Highlights from SNMMI 2024
An Overview of the Fundamentals of PET-CT Imaging
An Overview of the Fundamentals of PET-CT Imaging
Project Oncology®
An Overview of the Fundamentals of PET-CT Imaging

26/11